Liang Ma

机构：Guangxi Medical University

发表论文 12 篇 · 总被引 66 次 · h-index 4

代表论文

• Effect of bone marrow mesenchymal stem cells on the polarization of macrophages (2018 · Molecular Medicine Reports · 被引 42)
• First-line tislelizumab and ociperlimab combined with gemcitabine and cisplatin in advanced biliary tract cancer (ZSAB-TOP): a multicenter, single-arm, phase 2 study (2025 · Signal Transduction and Targeted Therapy · 被引 8)
• Enhanced visible light photocatalytic activity of octopod Ag 3 PO 4 microcrystals with high index crystal faces (2024 · RSC Advances · 被引 6)
• ZSAB-TOP: A phase 2 trial of tislelizumab (TIS) and ociperlimab (OCI) combined with gemcitabine and cisplatin (GemCis) as the first-line treatment for advanced biliary tract cancer (BTC). (2024 · Journal of Clinical Oncology · 被引 4)
• Prognostic Usefulness of Clinical Complete Response after PD-1 Inhibitor-Based Combination Therapy for Unresectable Hepatocellular Carcinoma (GUIDANCE006) (2025 · Liver Cancer · 被引 3)
• [Repair of soft tissue defect in hand or foot with lobulated medial sural artery perforator flap]. (2015 · PubMed · 被引 2)